Here are six quick takeaways:
1. Mr. Buckman has more than 30 years of experience in the medical device and medical technology industries, and has held positions at companies such as Pathway Medical Technologies and St. Jude Medical.
2. Mr. Timko most recently served as CEO of Blue Belt Technologies, which Smith & Nephew acquired earlier this year. He has also previously served as president of Carl Zeiss Surgical.
3. With 27 years of medical technology industry experience, Mr. Mazzocchi has served as executive chairman of Vascular Pathways.
4. Jon Wickwire and David Goodman resigned from Xtant Medical’s board.
5. Additionally, David Kirschman, MD, is stepping down from his role as executive vice president and chief scientific officer of Xtant Medical, to focus on his continuing role as an Xtant board member.
6. The above changes will be effective from July 2 onwards.
More articles on devices:
Wall Street analysts set $60 price target on NuVasive shares: 4 notes
Zimmer Biomet, SI-BONE, Amendia & more: 18 key notes
OrthoPediatrics files $75M IPO: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
